ArticleClinical journal of gastroenterology2023
A case of complete response with rechallenge-lenvatinib plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma refractory to multiple molecular-targeted agent treatments.
Tetsu Tomonari et al.PubMed ↗Publisher ↗
No numbers read from the abstract.